Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: A case report

L. Mannaerts, C. P. Bleeker-Rovers, M. Koopman, C. J A Punt, C. M L van Herpen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

Pylephlebitis or septic thrombophlebitis of the portal vein is a rare entity with a high mortality rate. It is often a complication of intra-abdominal infection most commonly caused by diverticulitis and appendicitis. Diagnosis is often delayed since clinical signs and symptoms are nonspecific. Pylephlebitis should be considered in patients with sepsis due to gut-associated organisms without a clear focus of infection. We describe a patient with metastastatic colon carcinoma treated with chemotherapy and bevacizumab who was diagnosed with pylephlebitis after a duodenal ulcer and responded well to antibiotic treatment.

Original languageEnglish
Pages (from-to)69-71
Number of pages3
JournalNetherlands Journal of Medicine
Volume67
Issue number2
Publication statusPublished - Feb 2009

Keywords

  • Chemotherapy
  • Colon carcinoma
  • Duodenal ulcer
  • Pylephlebitis

Fingerprint

Dive into the research topics of 'Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: A case report'. Together they form a unique fingerprint.

Cite this